Is ERNA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ERNA. It does not provide personalized investment advice.

ERNA (Ernexa Therapeutics Inc. Common Stock) Stock Analysis - Financials

Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of September 14, 2026, ERNA trades at $4.30 with a market cap of $4.86M and a P/E ratio of -1.93. ERNA moved +0.00% today. Year to date, ERNA is -85.76%; over the trailing twelve months it is -87.93%. Its 52-week range spans $3.18 to $276.75. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ERNA's key financials?

ERNA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ERNA recently traded at $4.30. Market cap is $4.86M. P/E ratio is -1.93. Revenue is $0.

ERNA Key Metrics

Key financial metrics for ERNA
Metric	Value
Price	$4.30
Market Cap	$4.86M
P/E Ratio	-1.93
EPS	$-2.24
Dividend Yield	0.00%
52-Week High	$276.75
52-Week Low	$3.18
Volume	4.84K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-14.08M
Gross Margin	0.00%

ERNA Analyst Consensus

ERNA analyst coverage data. Average price target: $0.00.

Common questions about ERNA

What are ERNA's key financials?: ERNA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ERNA recently traded at $4.30. Market cap is $4.86M. P/E ratio is -1.93. Revenue is $0.
Is ERNA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ERNA. It does not provide personalized investment advice.